Drugs / PGG beta-glucan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01269385 | Jan 2011 → Jun 2014 | B-cell chronic lymphocytic leukemia | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PGG beta-glucan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01269385 ↗ |
| Route | Intravenous | “PGG beta-glucan intravenously (IV) over 2-4 hours” NCT01269385 ↗ |